• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开启健康与疾病状态下体内外推断入口的肾脏研究钥匙:第一部分:体外系统与生理数据。

Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.

机构信息

Centre for Applied Pharmacokinetic Research, Manchester Pharmacy School, University of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT, UK.

DMPK, Oncology iMed, AstraZeneca R&D Alderley Park, Macclesfield, Cheshire, UK.

出版信息

AAPS J. 2016 Sep;18(5):1067-1081. doi: 10.1208/s12248-016-9942-x. Epub 2016 Jun 30.

DOI:10.1208/s12248-016-9942-x
PMID:27365096
Abstract

The programme for the 2015 AAPS Annual Meeting and Exhibition (Orlando, FL; 25-29 October 2015) included a sunrise session presenting an overview of the state-of-the-art tools for in vitro-in vivo extrapolation (IVIVE) and mechanistic prediction of renal drug disposition. These concepts are based on approaches developed for prediction of hepatic clearance, with consideration of scaling factors physiologically relevant to kidney and the unique and complex structural organisation of this organ. Physiologically relevant kidney models require a number of parameters for mechanistic description of processes, supported by quantitative information on renal physiology (system parameters) and in vitro/in silico drug-related data. This review expands upon the themes raised during the session and highlights the importance of high quality in vitro drug data generated in appropriate experimental setup and robust system-related information for successful IVIVE of renal drug disposition. The different in vitro systems available for studying renal drug metabolism and transport are summarised and recent developments involving state-of-the-art technologies highlighted. Current gaps and uncertainties associated with system parameters related to human kidney for the development of physiologically based pharmacokinetic (PBPK) model and quantitative prediction of renal drug disposition, excretion, and/or metabolism are identified.

摘要

2015 年 AAPS 年会和展览(佛罗里达州奥兰多;2015 年 10 月 25-29 日)的计划包括一个日出会议,概述了用于体外-体内外推(IVIVE)和肾脏药物处置的机制预测的最新工具。这些概念基于为预测肝脏清除率而开发的方法,考虑了与肾脏相关的生理缩放因子以及该器官的独特而复杂的结构组织。生理相关的肾脏模型需要许多参数来对过程进行机制描述,并辅以有关肾脏生理学(系统参数)和体外/计算机药物相关数据的定量信息。本综述扩展了会议期间提出的主题,并强调了高质量的体外药物数据在适当的实验设置和稳健的系统相关信息对于成功进行肾脏药物处置的 IVIVE 的重要性。总结了用于研究肾脏药物代谢和转运的不同体外系统,并强调了涉及最先进技术的最新发展。确定了与人类肾脏相关的系统参数开发生理相关药代动力学(PBPK)模型和定量预测肾脏药物处置、排泄和/或代谢方面的当前差距和不确定性。

相似文献

1
Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part I: In Vitro Systems and Physiological Data.开启健康与疾病状态下体内外推断入口的肾脏研究钥匙:第一部分:体外系统与生理数据。
AAPS J. 2016 Sep;18(5):1067-1081. doi: 10.1208/s12248-016-9942-x. Epub 2016 Jun 30.
2
Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.开启健康与疾病中体外表型研究的肾脏入路关键:第二部分:机制模型与体外表型研究。
AAPS J. 2016 Sep;18(5):1082-1094. doi: 10.1208/s12248-016-9959-1. Epub 2016 Aug 9.
3
Evaluation and Quantitative Prediction of Renal Transporter-Mediated Drug-Drug Interactions.肾转运体介导的药物相互作用的评估与定量预测
J Clin Pharmacol. 2016 Jul;56 Suppl 7:S110-21. doi: 10.1002/jcph.702.
4
Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.转运体-酶相互作用:利用静态和动态机制模型解析肝脏转运体和酶对药物处置的影响
J Clin Pharmacol. 2016 Jul;56 Suppl 7:S99-S109. doi: 10.1002/jcph.695.
5
Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.用于预测被动肾小管重吸收和肾排泄清除率的新型最小生理模型。
Eur J Pharm Sci. 2016 Oct 30;94:59-71. doi: 10.1016/j.ejps.2016.03.018. Epub 2016 Mar 28.
6
Absolute abundance and function of intestinal drug transporters: a prerequisite for fully mechanistic in vitro-in vivo extrapolation of oral drug absorption.肠内药物转运体的绝对含量和功能:口服药物吸收的完全机制体外-体内外推的前提条件。
Biopharm Drug Dispos. 2013 Jan;34(1):2-28. doi: 10.1002/bdd.1810. Epub 2012 Oct 8.
7
In vitro-in vivo extrapolation method to predict human renal clearance of drugs.预测药物人体肾清除率的体外-体内外推法。
J Pharm Sci. 2014 Mar;103(3):994-1001. doi: 10.1002/jps.23851. Epub 2014 Jan 13.
8
Toward a new paradigm for the efficient in vitro-in vivo extrapolation of metabolic clearance in humans from hepatocyte data.从肝细胞数据推断人体代谢清除率的体外-体内外推新范例。
J Pharm Sci. 2013 Sep;102(9):3239-51. doi: 10.1002/jps.23502. Epub 2013 Mar 12.
9
Towards Further Verification of Physiologically-Based Kidney Models: Predictability of the Effects of Urine-Flow and Urine-pH on Renal Clearance.进一步验证基于生理学的肾脏模型:尿液流量和尿液 pH 值对肾清除率影响的可预测性。
J Pharmacol Exp Ther. 2019 Feb;368(2):157-168. doi: 10.1124/jpet.118.251413. Epub 2018 Nov 9.
10
Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.通过在体外-体内外推方法中结合代谢、转运和通透性数据来预测总肝清除率:重点关注药物在肝脏中的表观未结合分数。
J Pharm Sci. 2013 Jul;102(7):2085-95. doi: 10.1002/jps.23562. Epub 2013 Apr 23.

引用本文的文献

1
Human and rat renal proximal tubule in vitro models for ADME applications.用于药物吸收、分布、代谢和排泄(ADME)研究的人源和大鼠肾近端小管体外模型。
Arch Toxicol. 2025 May;99(5):1613-1641. doi: 10.1007/s00204-025-03987-4. Epub 2025 Mar 4.
2
An in vitro-in silico workflow for predicting renal clearance of PFAS.一种用于预测 PFAS 肾清除率的体外-计算工作流程。
Toxicol Appl Pharmacol. 2024 Aug;489:117015. doi: 10.1016/j.taap.2024.117015. Epub 2024 Jun 23.
3
Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans.

本文引用的文献

1
Large-scale multiplex absolute protein quantification of drug-metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH-MS: Comparison with MRM/SRM and HR-MRM/PRM.采用SWATH-MS对人肠、肝和肾微粒体中药物代谢酶和转运蛋白进行大规模多重绝对蛋白定量:与MRM/SRM和HR-MRM/PRM的比较
Proteomics. 2016 Aug;16(15-16):2106-17. doi: 10.1002/pmic.201500433. Epub 2016 Jul 8.
2
Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.用于预测被动肾小管重吸收和肾排泄清除率的新型最小生理模型。
Eur J Pharm Sci. 2016 Oct 30;94:59-71. doi: 10.1016/j.ejps.2016.03.018. Epub 2016 Mar 28.
3
基于生理的药代动力学建模预测钠-葡萄糖协同转运蛋白2抑制剂恩格列净在人体内的药代动力学
Pharmaceutics. 2023 Mar 14;15(3):942. doi: 10.3390/pharmaceutics15030942.
4
Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment.为了在化学风险评估中更好地利用和接受通用基于生理的动力学 (PBK) 模型进行体外-体内外推 (IVIVE),实现最佳效果。
Arch Toxicol. 2022 Dec;96(12):3407-3419. doi: 10.1007/s00204-022-03356-5. Epub 2022 Sep 5.
5
IVIVE: Facilitating the Use of Toxicity Data in Risk Assessment and Decision Making.体外体内外推法:助力毒性数据在风险评估与决策制定中的应用
Toxics. 2022 May 1;10(5):232. doi: 10.3390/toxics10050232.
6
Application of the Adverse Outcome Pathway Concept to Nephrotoxicity Assessment: Kidney Injury due to Receptor-Mediated Endocytosis and Lysosomal Overload as a Case Study.不良结局途径概念在肾毒性评估中的应用:以受体介导的内吞作用和溶酶体过载导致的肾损伤为例的研究。
Front Toxicol. 2022 Apr 19;4:864441. doi: 10.3389/ftox.2022.864441. eCollection 2022.
7
PBPK Simulation-Based Evaluation of Ganciclovir Crystalluria Risk Factors: Effect of Renal Impairment, Old Age, and Low Fluid Intake.基于 PBPK 模拟的更昔洛韦结晶尿风险因素评估:肾功能损害、老年和低液体摄入的影响。
AAPS J. 2021 Dec 14;24(1):13. doi: 10.1208/s12248-021-00654-1.
8
Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system.通过建立肾脏近端小管微生理系统中阿片类药物处置模型,弥合计算与体内的差距。
Sci Rep. 2021 Nov 1;11(1):21356. doi: 10.1038/s41598-021-00338-y.
9
The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.细胞培养技术与计算机模拟模型相结合助力药物研发。
Pharmaceutics. 2021 May 12;13(5):704. doi: 10.3390/pharmaceutics13050704.
10
In Vivo-to-In Vitro Extrapolation of Transporter-Mediated Renal Clearance: Relative Expression Factor Versus Relative Activity Factor Approach.体内至体外外推转运体介导的肾清除率:相对表达因子与相对活性因子方法。
Drug Metab Dispos. 2020 Jun;49(6):470-478. doi: 10.1124/dmd.121.000367. Epub 2021 Apr 6.
Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
二甲双胍与西咪替丁:基于生理的药代动力学建模以研究转运体介导的药物相互作用
Eur J Pharm Sci. 2016 Jun 10;88:70-82. doi: 10.1016/j.ejps.2016.03.020. Epub 2016 Mar 25.
4
A Human Renal Proximal Tubule Cell Line with Stable Organic Anion Transporter 1 and 3 Expression Predictive for Antiviral-Induced Toxicity.一种具有稳定有机阴离子转运体1和3表达的人近端肾小管细胞系,可预测抗病毒诱导的毒性。
AAPS J. 2016 Mar;18(2):465-75. doi: 10.1208/s12248-016-9871-8. Epub 2016 Jan 28.
5
Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance.肾药物和外源性物质葡萄糖醛酸化清除率的体外-体内外推(IV-IVE)的缩放因子。
Br J Clin Pharmacol. 2016 Jun;81(6):1153-64. doi: 10.1111/bcp.12889. Epub 2016 Mar 14.
6
Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening.芯片肾技术用于药物诱导的肾毒性筛选。
Trends Biotechnol. 2016 Feb;34(2):156-170. doi: 10.1016/j.tibtech.2015.11.001. Epub 2015 Dec 18.
7
Quantitative Targeted Absolute Proteomics for 28 Transporters in Brush-Border and Basolateral Membrane Fractions of Rat Kidney.大鼠肾脏刷状缘和基底外侧膜组分中28种转运蛋白的定量靶向绝对蛋白质组学
J Pharm Sci. 2016 Feb;105(2):1011-1016. doi: 10.1002/jps.24645. Epub 2016 Jan 11.
8
Declining Estimated Glomerular Filtration Rate and Its Association with Mortality and Comorbidity Over 10 Years in Elderly Women.老年女性10年间估计肾小球滤过率下降及其与死亡率和合并症的关联
Nephron. 2015;130(4):245-55. doi: 10.1159/000435790. Epub 2015 Jul 15.
9
Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.液相色谱-串联质谱定量蛋白质组学在药物代谢与转运的体外-体内外推中的转化价值及选择合适技术的考量
Expert Opin Drug Metab Toxicol. 2015;11(9):1357-69. doi: 10.1517/17425255.2015.1055245. Epub 2015 Jun 26.
10
Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.药物转运体的人类个体发育:儿科转运体工作组的综述与建议
Clin Pharmacol Ther. 2015 Sep;98(3):266-87. doi: 10.1002/cpt.176.